Asia Deal Watch: Takeda Licenses Curadev STING Agonist To Further Its IO Ambitions

 
• By Ian Haydock, Brian Yang, Anju Ghangurde, Jung Won Shin, and Joseph Haas
  
asian man in bed suffering insomnia and sleep disorder thinking about his problem at night - Image
Eisai now owns all rights to insomnia candidate lemborexant

More from Deals

More from Business